FDA
- Status: approved
🇺🇸 Novel hormonal therapy in United States
Novel hormonal therapy (novel-hormonal-therapy) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 200000.00 per year
Novel hormonal therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Novel hormonal therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Novel hormonal therapy in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Novel hormonal therapy cost in United States?
annual_list: USD 200000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.